Please ensure Javascript is enabled for purposes of website accessibility

Here's Why Wells Fargo and Other Big Bank Stocks Were Soaring on Monday

By Matthew Frankel, CFP® – May 18, 2020 at 2:55PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

A small piece of promising news on the coronavirus vaccine front is giving investors hope.

What happened

The stock market was having an extremely strong day on Monday. As of 3:50 p.m. EDT, the Dow Jones Industrial Average was up by more than 4% and the S&P 500 index wasn't far behind.

The financial sector was among the market's best performers, with the biggest bank stocks all well into the green. Wells Fargo (WFC -0.69%) and Citigroup (C -1.70%) were the leaders out of the "big four" U.S. banks, with both up by more than 9%. Bank of America (BAC -1.50%) and JPMorgan Chase (JPM -1.56%) weren't doing too bad either, posting gains of more than 7% and 6%, respectively. So, let's take a look at why the stock market was performing so well on Monday and why the big banks were doing even better.

Crowd of people cheering.

Image source: Getty Images.

So what

The biggest market catalyst Monday was the announcement that Moderna's (NASDAQ: MRNA) COVID-19 vaccine candidate is showing promising results in early stage clinical trials. To be fair, the trial has an extremely small sample size (45 people) and the data from it is still incomplete. Even so, the fact that all 45 patients produced antibodies to SARS-CoV-2 is a promising sign. The report also indicated that the vaccine was "generally safe and well tolerated," by patients, which is certainly nice to hear in a trial where the primary purpose is to assess safety.

So, what does this have to do with bank stocks?

More than you might think, actually. While the banking business is obviously more complex than can be addressed in a paragraph or two, the big banks mentioned here need two main things to get back to normal. First, they need to avoid a massive wave of loan defaults. All four have recently set aside billions more in loss reserves, which should help them weather a short-term uptick in defaults. But if U.S. borrowers end up having trouble paying their bills on a wide scale, those reserves might not be enough.

Second, banks rely on consumers and businesses being willing and able to spend money. They need people to buy cars and take out auto loans. They need creditworthy consumers to use their credit cards. If the COVID-19 pandemic lasts for significantly longer than anticipated, consumer demand for loans could stay very low.

Now what

Here's the point. Many experts have said that fiscal stimulus certainly helps, and the emergency use authorizations for some potentially effective therapeutics like remdesivir certainly help, but for the economy to really begin getting back to something close to normal, we're going to need an effective vaccine for SARS-CoV-2. The sooner such a vaccine becomes widely available, the sooner banks can (hopefully) see defaults and loan originations return to normal levels.

To be fair, investors should take Monday's vaccine news with a grain of salt. This is a very small amount of data from a very early-stage clinical trial. But since they were the first results we've seen from a vaccine trial and they were positive, it's natural to view it as a hopeful step in the right direction.

Matthew Frankel, CFP owns shares of Bank of America. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Citigroup Inc. Stock Quote
Citigroup Inc.
C
$41.67 (-1.70%) $0.72
Bank of America Corporation Stock Quote
Bank of America Corporation
BAC
$30.20 (-1.50%) $0.46
JPMorgan Chase & Co. Stock Quote
JPMorgan Chase & Co.
JPM
$104.50 (-1.56%) $-1.66
Wells Fargo & Company Stock Quote
Wells Fargo & Company
WFC
$40.22 (-0.69%) $0.28

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
326%
 
S&P 500 Returns
102%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 10/02/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.